Pharmaceutical - Asia-Pacific

Filter

Current filters:

Asia-Pacific

Popular Filters

51 to 75 of 775 results

China pharma industry sees steady growth

25-02-2014

China's pharmaceutical industry, despite the challenges resulted from sluggish economies in the European…

Asia-PacificChinaMarkets & MarketingPharmaceutical

Novartis gets fourth indication, DME, for Lucentis in Japan

24-02-2014

Swiss drug major Novartis says it has received approval from Japanese regulatory bodies for a fourth…

Asia-PacificJapanLucentisNovartisOphthalmicsPharmaceuticalRegulation

Takeda re-aligns marketing system in Japan

24-02-2014

Japan’s largest drugmaker Takeda Pharmaceutical says it decided to re-align its marketing system in…

Asia-PacificJapanManagementMarkets & MarketingPharmaceuticalTakeda Pharmaceuticals

Dilafor partners with Lee’s Pharmaceutical for tafoxiparin

24-02-2014

Sweden-based Dilafor AB, a Karolinska Development portfolio company, and Lee’s Pharmaceutical Holdings,…

Asia-PacificChinaDilafor ABKarolinska DevelopmentLee's PharmaceuticalLicensingPharmaceuticalReproductivetafoxiparinWomen's Health

Indian drugmakers readying for next “Patent cliff”

24-02-2014

The strategic drug reviews, as well as mergers and acquisitions – such as Actavis buying out Forest…

Asia-PacificGenericsIndiaMergers & AcquisitionsPatentsPharmaceuticalRegulation

China's medical foreign trade maintained growth in 2013

23-02-2014

Statistics from China’s CCCMHPIE (Chamber of Commerce for Import & Export if Medicines & Health Products)…

Asia-PacificChinaMarkets & MarketingPharmaceutical

Merck & Co partners with Cipla for Indian marketing of raltegravir

Merck & Co partners with Cipla for Indian marketing of raltegravir

21-02-2014

US pharma giant Merck & Co, known as MSD outside North America, has announced the formation of an India-specific…

Anti-viralsAsia-PacificCiplaIndiaIsentressMarkets & MarketingMerck & CoPharmaceuticalRaltegravir Tablets

Setting the record straight: Australia’s PBS expenditure is in decline

21-02-2014

Comments made this week by Australia’s federal Health Minister, Peter Dutton MP, about expenditure…

Asia-PacificAustraliaFinancialGenericsHealthcarePharmaceutical

Funding restrictions for rituximab and eltrombopag widened in New Zealand

Funding restrictions for rituximab and eltrombopag widened in New Zealand

20-02-2014

New Zealand’s Pharmaceutical Management Agency PHARMAC has announced the approval of proposals to widen…

Asia-PacificeltrombopagFinancialGlaxoSmithKlineHealthcareImmunologicalsNew ZealandPharmaceuticalrituximabRoche

New NPS MedicineWise annual evaluation report indicates Australian PBS savings

New NPS MedicineWise annual evaluation report indicates Australian PBS savings

18-02-2014

The 16th NPS MedicineWise Annual Evaluation Report provides a snapshot of the organization’s progress…

Asia-PacificAustraliaFinancialHealthcarePharmaceutical

India’s patents moves could see particular uncertainty for diabetes sector

India’s patents moves could see particular uncertainty for diabetes sector

17-02-2014

The Indian government's decision to review patented drugs by multinationals, to allow for the manufacture…

Abbott LaboratoriesAsia-PacificDiabetesEli LillyIndiaMarkets & MarketingMerck & CoNovo NordiskPatentsPharmaceutical

ACCC acts on Pfizer’s alleged anti-competitive conduct in Australia

ACCC acts on Pfizer’s alleged anti-competitive conduct in Australia

13-02-2014

The Australian Competition and Consumer Commission revealed today that is has instituted proceedings…

Asia-PacificAustraliaCardio-vascularLegalLipitorMarkets & MarketingPfizerPharmaceutical

2014 to be transition year for Japan pharma

2014 to be transition year for Japan pharma

11-02-2014

2014 will be marked as a transition year for the Japanese Pharma industry – but the year is bound to…

Asia-PacificPharmaceuticalPricingRegulationResearch

Hisamitsu announces positive Phase II results for Parkinson’s disease drug

10-02-2014

Japanese drugmaker Hisamitsu Pharmaceutical’s has announced the results of a Phase II clinical study…

Asia-PacificHisamitsu PharmaLevodopaNeurologicalPharmaceuticalResearch

Kinex and PharmaEssentia expand drug development partnership

06-02-2014

Privately-held USA-based Kinex Pharmaceuticals and Taiwan’s PharmaEssentia say they have signed a new…

Asia-PacificKinex PharmaceuticalsLicensingOncologyOratecanOraxolPharmaceuticalPharmaEssentia

AbbVie to spend $320 million to establish Singapore manufacturing presence

AbbVie to spend $320 million to establish Singapore manufacturing presence

06-02-2014

US drugmaker AbbVie says it plans to invest $320 million to establish operations in Singapore for small…

AbbVieAsia-PacificImmunologicalsOncologyPharmaceuticalProduction

Australian industry calls on government to save the PBS

Australian industry calls on government to save the PBS

06-02-2014

Medicines Australia has called on the Australian government to save the Pharmaceutical Benefits Scheme…

Asia-PacificAustraliaHealthcarePatentsPharmaceuticalPolitics

Regulatory update on Indian clinical research approval timelines

04-02-2014

The Drug Controller General of India (DCGI) has provided written confirmation to the pharmaceutical industry…

Asia-PacificIndiaPharmaceuticalRegulationResearch

Sagent Pharma sets up research center in China

04-02-2014

US specialty drug firm Sagent Pharmaceuticals (Nasdaq: SGNT), which has a specific emphasis on the injectable…

Asia-PacificChinaPharmaceuticalResearchSagent Pharmaceuticals

Ferrer links with Ildong and Ergomed for lorediplon development

03-02-2014

Privately-held Spanish drugmaker Ferrer has executed two agreements, one with South Korea’s Ildong…

Asia-PacificErgomed Clinical ResearchFerrer InternacionalIldong PharmaLicensinglorediplonNeurologicalPharmaceuticalResearch

Pharma multinationals facing more pricing problems in India

Pharma multinationals facing more pricing problems in India

03-02-2014

Even as a battle royal appears to be brewing between India's drug price regulator, the National Pharma…

Asia-PacificAstraZenecaFinancialGlaxoSmithKlineIndiaNovartisPfizerPharmaceuticalPricing

AstraZeneca in licensing deal for MALT1 inhibitors; closes Bangalore R&D site

AstraZeneca in licensing deal for MALT1 inhibitors; closes Bangalore R&D site

31-01-2014

Belgium-based VIB, a non-profit research institute in life sciences, and the Center for Drug Design and…

Asia-PacificAstraZenecaIndiaInflammatory diseasesOncologyPharmaceuticalResearchTropical diseases

UCB and Biogen sign Asian license agreement for MS drugs

UCB and Biogen sign Asian license agreement for MS drugs

30-01-2014

Belgian drugmaker UCB and US biotech firm Biogen Idec have signed exclusive agreements granting UCB the…

AlprolixAsia-PacificBiogen IdecBiotechnologyEloctateLicensingNeurologicalPharmaceuticalTecfideraUCB

51 to 75 of 775 results

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top